EX-23.1 2 d287237dex231.htm EX-23.1 EX-23.1

Exhibit 23.1

 

  LOGO     
  

KPMG LLP

345 Park Avenue

New York, NY 10154-0102

Consent of Independent Registered Public Accounting Firm

We consent to the use of our audit report dated March 31, 2023, with respect to the consolidated financial statements of Lexeo Therapeutics, Inc., included herein, and to the reference to our firm under the heading “Experts” in the prospectus.

/s/ KPMG LLP

New York, New York

November 1, 2023

 

KPMG LLP, a Delaware limited liability partnership and a member firm of

the KPMG global organization of independent member firms affiliated with

KPMG International Limited, a private English company limited by guarantee.